Uploaded via media manager.

At ARC , Patients Can Also Participate in Critical Research

Community Impact Highlights Ongoing Studies

Austin Regional Clinic not only tends to its patients, it is also conducting important medical research – and seeking neighboring residents interested in participating in upcoming clinical trials.

The local newspaper Community Impact detailed how research at ARC Wilson Parke is investigating treatment for osteoarthritis and will soon include ailments such as asthma and Type 2 diabetes.

“Our goals are to provide patients with access to studies and medications that can benefit the community as a whole,” ARC Clinical Research Manager Grace Bullock explains.

Dr. Anurekha Chadha, ARC rheumatologist and medical director for the research program, says she’s seeking patients suffering from these ailments who may benefit from the potential treatments being studied. Said Dr. Chadha, “We look for patients who are not getting adequate relief (now). It gives them this pipeline of having an extra level of care available.”

ARC typically seeks patients living within a 10-mile radius of the clinic, located at 11714 Wilson Parke Ave. in the Four Points area in far west Austin. It is near Lake Travis and nearby communities, such as Cedar Park, Lakeway, Steiner Ranch, Volente and Lago Vista.

Criteria for study participation is strict. ARC evaluates potential participants’ overall health and medical history and confirms they are correctly diagnosed as being afflicted with osteoarthritis, asthma or Type 2 diabetes.

ARC’s osteoarthritis research already has exhibited some evidence of success for patients. It is a Phase 3 study, the last step before the proposed treatment is submitted for approval to the U.S. Food and Drug Administration, Chadha said. Local participants will be among a large number of patients throughout the U.S. – usually from several hundred to 3,000 – who usually participate in a Phase 3 study.

Read the full Community Impact story.

Learn more about ARC’s clinical research mission and opportunities to volunteer and participate in clinical studies.

For more information on the stages of pharmaceutical research, visit the U.S. National Institutes of Health clinical trials website.

Tags: ARC Wilson Parke, ARC Clinical Research, Dr. Anurekha Chadha, clinical trials, asthma, osteoarthritis, Type 2 diabetes

More on this Topic

Q&A with Medical Director of ARC Clinical Research

ARC’s new Clinical Research division aims to bring patients more access to treatments that might otherwise not be available to them. Dr. Anurekha Chadha, Medical Director for the new division, explains how patients can enroll in the upcoming trials in an interview with Four Point News.

ARC Clinical Research now open at ARC Wilson Parke

ARC is excited to announce the expansion of our clinical research program. ARC Clinical Research, opened Tuesday, November 1, at ARC Wilson Parke, offering more patients access to cutting-edge research beyond the rheumatology clinical trials ARC currently conducts.

ARC Teams with Austin-based ENTvantage Diagnostics Dx for New Clinical Trial

ARC’s newest clinical trial tests a device that could help curb antibiotic overuse, "one of the most urgent threats to the public’s health,” according to the Centers for Disease Control (CDC).

ARC Clinical Research Featured in Community Impact

ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.

ARC Clinical Research Studying Anti-Flu Drug in High-Risk Patients

ARC Clinical Research has been studying a new drug to fight the flu in high-risk patients, with the goal of being able to offer another flu treatment choice to patients in the future.